Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
25 Nov 2024 |
AA |
Unaudited abridged accounts made up to 29 February 2024
|
|
|
18 Sep 2024 |
AD03 |
Register(s) moved to registered inspection location Immunoclin Manufacturing Facility C/O Medical Technologies Innovation Facility(Mtif) Clifton Campus, Nottignham Trent University Nottingham NG11 8NS
|
|
|
18 Sep 2024 |
AD02 |
Register inspection address has been changed to Immunoclin Manufacturing Facility C/O Medical Technologies Innovation Facility(Mtif) Clifton Campus, Nottignham Trent University Nottingham NG11 8NS
|
|
|
26 Jul 2024 |
CS01 |
Confirmation statement made on 26 July 2024 with no updates
|
|
|
13 Nov 2023 |
AA |
Unaudited abridged accounts made up to 28 February 2023
|
|
|
02 Aug 2023 |
CS01 |
Confirmation statement made on 26 July 2023 with updates
|
|
|
20 Nov 2022 |
AA |
Total exemption full accounts made up to 28 February 2022
|
|
|
26 Jul 2022 |
CS01 |
Confirmation statement made on 26 July 2022 with updates
|
|
|
23 Jun 2022 |
PSC07 |
Cessation of Maitland Pharma Corp as a person with significant control on 23 January 2022
|
|
|
24 Nov 2021 |
AA |
Total exemption full accounts made up to 28 February 2021
|
|
|
25 Oct 2021 |
CS01 |
Confirmation statement made on 11 October 2021 with no updates
|
|
|
23 Feb 2021 |
AA |
Total exemption full accounts made up to 29 February 2020
|
|
|
21 Nov 2020 |
CS01 |
Confirmation statement made on 11 October 2020 with no updates
|
|
|
21 Nov 2019 |
AA |
Total exemption full accounts made up to 28 February 2019
|
|
|
24 Oct 2019 |
CS01 |
Confirmation statement made on 11 October 2019 with updates
|
|
|
24 Oct 2019 |
PSC02 |
Notification of Maitland Pharma Corp as a person with significant control on 7 May 2019
|
|
|
05 Dec 2018 |
AA |
Total exemption full accounts made up to 28 February 2018
|
|
|
24 Oct 2018 |
CS01 |
Confirmation statement made on 11 October 2018 with no updates
|
|
|
06 Dec 2017 |
AA |
Total exemption full accounts made up to 28 February 2017
|
|
|
12 Oct 2017 |
PSC05 |
Change of details for Dr Dorothy H Bray as a person with significant control on 11 October 2017
|
|
|
11 Oct 2017 |
CS01 |
Confirmation statement made on 11 October 2017 with updates
|
|
|
11 Oct 2017 |
PSC05 |
Change of details for Immunoclin Corporation as a person with significant control on 11 October 2017
|
|
|
11 Oct 2017 |
AA01 |
Previous accounting period extended from 31 January 2017 to 28 February 2017
|
|
|
22 Feb 2017 |
CH03 |
Secretary's details changed for Mr Jonathan Leslie Bray on 22 February 2017
|
|
|
22 Feb 2017 |
CH01 |
Director's details changed for Mr Jonathan Leslie Bray on 22 February 2017
|
|